AAAAAA

   
Results: 1-22 |
Results: 22
DEVELOPMENT OF AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR MEASUREMENT OF SERUM-ASSOCIATED ALX40-4C
Authors: PAYETTE PJ CORMIER M DABEK B YUNGBLUT P PRESSEAULT S CLIMIE S SAHAI J CAMERON WD FILION LG
Citation: Pj. Payette et al., DEVELOPMENT OF AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR MEASUREMENT OF SERUM-ASSOCIATED ALX40-4C, Clinical and diagnostic laboratory immunology, 4(6), 1997, pp. 671-675
PHARMACOKINETICS OF ANTIMYCOBACTERIAL DRUGS IN PATIENTS WITH TUBERCULOSIS, AIDS, AND DIARRHEA
Authors: CHOUDHRI SH HAWKEN M GATHUA S MINYIRI GO WATKINS W SAHAI J SITAR DS AOKI FY LONG R
Citation: Sh. Choudhri et al., PHARMACOKINETICS OF ANTIMYCOBACTERIAL DRUGS IN PATIENTS WITH TUBERCULOSIS, AIDS, AND DIARRHEA, Clinical infectious diseases, 25(1), 1997, pp. 104-111
OCULAR PENETRATION AND ANTIMYCOBACTERIAL ACTIVITY OF INH AND PYRAZINAMIDE
Authors: YU E TOYE B SAHAI J HODGE W
Citation: E. Yu et al., OCULAR PENETRATION AND ANTIMYCOBACTERIAL ACTIVITY OF INH AND PYRAZINAMIDE, Investigative ophthalmology & visual science, 38(4), 1997, pp. 4069-4069
RIFABUTIN INDUCED UVEITIS IN A RABBIT MODEL
Authors: JOHNSON TM LI S BROWNSTEIN S SAHAI J HODGE W
Citation: Tm. Johnson et al., RIFABUTIN INDUCED UVEITIS IN A RABBIT MODEL, Investigative ophthalmology & visual science, 38(4), 1997, pp. 5167-5167
RIFABUTIN ABSORPTION IN THE GUT UNALTERED BY CONCOMITANT ADMINISTRATION OF DIDANOSINE IN AIDS PATIENTS
Authors: LI RC NARANG PK SAHAI J CAMERON W BIANCHINE JR
Citation: Rc. Li et al., RIFABUTIN ABSORPTION IN THE GUT UNALTERED BY CONCOMITANT ADMINISTRATION OF DIDANOSINE IN AIDS PATIENTS, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1566-1570
REDUCED PLASMA-CONCENTRATIONS OF ANTITUBERCULOSIS DRUGS IN PATIENTS WITH HIV-INFECTION
Authors: SAHAI J GALLICANO K SWICK L TAILOR S GARBER G SEGUIN I OLIVERAS L WALKER S RACHLIS A CAMERON DW
Citation: J. Sahai et al., REDUCED PLASMA-CONCENTRATIONS OF ANTITUBERCULOSIS DRUGS IN PATIENTS WITH HIV-INFECTION, Annals of internal medicine, 127(4), 1997, pp. 289-293
LACK OF GENDER EFFECT ON CIPROFLOXACIN PHARMACOKINETICS IN HUMANS
Authors: GALLICANO K SAHAI J
Citation: K. Gallicano et J. Sahai, LACK OF GENDER EFFECT ON CIPROFLOXACIN PHARMACOKINETICS IN HUMANS, British journal of clinical pharmacology, 42(5), 1996, pp. 632-634
SAQUINAVIR DRUG-INTERACTIONS AGAINST HUMAN CYTOCHROME-P-450 3A4
Authors: FOSTER BC WILSON DL GALLICANO K SAHAI J BOUCHARD J
Citation: Bc. Foster et al., SAQUINAVIR DRUG-INTERACTIONS AGAINST HUMAN CYTOCHROME-P-450 3A4, AIDS, 10, 1996, pp. 26-26
RISKS AND SYNERGIES FROM DRUG-INTERACTIONS
Authors: SAHAI J
Citation: J. Sahai, RISKS AND SYNERGIES FROM DRUG-INTERACTIONS, AIDS, 10, 1996, pp. 21-25
REDUCED ORAL ABSORPTION OF TUBERCULOSIS DRUGS IN HIV-INFECTION
Authors: SAHAI J SWICK L TAILOR S GALLICANO K GARBER G RACHLIS A CAMERON DW
Citation: J. Sahai et al., REDUCED ORAL ABSORPTION OF TUBERCULOSIS DRUGS IN HIV-INFECTION, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 51-51
A PHASE-I EVALUATION OF CONCOMITANT RIFABUTIN AND DIDANOSINE IN SYMPTOMATIC HIV-INFECTED PATIENTS
Authors: SAHAI J NARANG PK HAWLEYFOSS N LI RC KAMAL M CAMERON DW
Citation: J. Sahai et al., A PHASE-I EVALUATION OF CONCOMITANT RIFABUTIN AND DIDANOSINE IN SYMPTOMATIC HIV-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 9(3), 1995, pp. 274-279
PHARMACOKINETICS OF SIMULTANEOUSLY ADMINISTERED ZIDOVUDINE AND DIDANOSINE IN HIV-SEROPOSITIVE MALE-PATIENTS
Authors: SAHAI J GALLICANO K GARBER G PAKUTS A CAMERON W
Citation: J. Sahai et al., PHARMACOKINETICS OF SIMULTANEOUSLY ADMINISTERED ZIDOVUDINE AND DIDANOSINE IN HIV-SEROPOSITIVE MALE-PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10(1), 1995, pp. 54-60
EFFECT OF RIFABUTIN ON THE PHARMACOKINETICS OF ZIDOVUDINE IN PATIENTSINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: GALLICANO K SAHAI J SWICK L SEGUIN I PAKUTS A CAMERON DW
Citation: K. Gallicano et al., EFFECT OF RIFABUTIN ON THE PHARMACOKINETICS OF ZIDOVUDINE IN PATIENTSINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21(4), 1995, pp. 1008-1011
EFFECT OF AZOLES ON THE GLUCURONIDATION OF ZIDOVUDINE BY HUMAN LIVER UDP-GLUCURONOSYLTRANSFERASE - REPLY
Authors: GALLICANO K SAHAI J
Citation: K. Gallicano et J. Sahai, EFFECT OF AZOLES ON THE GLUCURONIDATION OF ZIDOVUDINE BY HUMAN LIVER UDP-GLUCURONOSYLTRANSFERASE - REPLY, The Journal of infectious diseases, 172(6), 1995, pp. 1635-1636
EFFECTS OF THE ANTACIDS IN DIDANOSINE TABLETS ON DAPSONE PHARMACOKINETICS
Authors: SAHAI J GARBER G GALLICANO K OLIVERAS L CAMERON DW
Citation: J. Sahai et al., EFFECTS OF THE ANTACIDS IN DIDANOSINE TABLETS ON DAPSONE PHARMACOKINETICS, Annals of internal medicine, 123(8), 1995, pp. 584-587
AVOIDING THE CIPROFLOXACIN DIDANOSINE INTERACTION
Authors: SAHAI J
Citation: J. Sahai, AVOIDING THE CIPROFLOXACIN DIDANOSINE INTERACTION, Annals of internal medicine, 123(5), 1995, pp. 394-395
RELATIONSHIP BETWEEN BODY-WEIGHT, BODY-SURFACE AREA AND SERUM ZIDOVUDINE PHARMACOKINETIC PARAMETERS IN ADULT, MALE HIV-INFECTED PATIENTS
Authors: SAHAI J GALLICANO K ORMSBY E GARBER G CAMERON DW
Citation: J. Sahai et al., RELATIONSHIP BETWEEN BODY-WEIGHT, BODY-SURFACE AREA AND SERUM ZIDOVUDINE PHARMACOKINETIC PARAMETERS IN ADULT, MALE HIV-INFECTED PATIENTS, AIDS, 8(6), 1994, pp. 793-796
EFFECT OF BISMUTH SUBSALICYLATE ON CIPROFLOXACIN BIOAVAILABILITY
Authors: RAMBOUT L SAHAI J GALLICANO K OLIVERAS L GARBER G
Citation: L. Rambout et al., EFFECT OF BISMUTH SUBSALICYLATE ON CIPROFLOXACIN BIOAVAILABILITY, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2187-2190
EFFECT OF ANTACIDS IN DIDANOSINE TABLET ON BIOAVAILABILITY OF ISONIAZID
Authors: GALLICANO K SAHAI J ZARORBEHRENS G PAKUTS A
Citation: K. Gallicano et al., EFFECT OF ANTACIDS IN DIDANOSINE TABLET ON BIOAVAILABILITY OF ISONIAZID, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 894-897
EFFECT OF FLUCONAZOLE ON ZIDOVUDINE PHARMACOKINETICS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: SAHAI J GALLICANO K PAKUTS A CAMERON DW
Citation: J. Sahai et al., EFFECT OF FLUCONAZOLE ON ZIDOVUDINE PHARMACOKINETICS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infectious diseases, 169(5), 1994, pp. 1103-1107
PHARMACOKINETICS OF ZIDOVUDINE AFTER THE INITIAL SINGLE-DOSE AND DURING CHRONIC-DOSE THERAPY IN HIV-INFECTED PATIENTS
Authors: GALLICANO K SAHAI J ORMSBY E CAMERON DW PAKUTS A MCGILVERAY I
Citation: K. Gallicano et al., PHARMACOKINETICS OF ZIDOVUDINE AFTER THE INITIAL SINGLE-DOSE AND DURING CHRONIC-DOSE THERAPY IN HIV-INFECTED PATIENTS, British journal of clinical pharmacology, 36(2), 1993, pp. 128-131
OVERVIEW OF THE IMMUNE AND HEMATOPOIETIC SYSTEMS
Authors: SAHAI J LOUIE SG
Citation: J. Sahai et Sg. Louie, OVERVIEW OF THE IMMUNE AND HEMATOPOIETIC SYSTEMS, American journal of hospital pharmacy, 50(7), 1993, pp. 4-9
Risultati: 1-22 |